Vaccine-therapy.

  • Dwinell, William Grout, 1878-
Date:
1911
Catalogue details

Licence: Public Domain Mark

Credit: Vaccine-therapy. Source: Wellcome Collection.

Provider: This material has been provided by the Harvey Cushing/John Hay Whitney Medical Library at Yale University, through the Medical Heritage Library. The original may be consulted at the Harvey Cushing/John Hay Whitney Medical Library at Yale University.

    49/58 (page 41)
    joint. Swelling of tendons or tendon sheaths in the neighborhood of joint or elsewhere. Muscular pains, diffuse and irregular in distribution and origin. Neu- ralgia of trigeminal type. Anaemia. Group B. No definite arthritis; inflammation, or swelling of tendon sheath or tendon. Diffuse muscular pains, irregular in distribution and origin. Occasional swelling of joints or tendons, clearing up and leaving no objective symp- toms. Palpitation, with irregularity of heart action. Tachycardia. Neuralgia, trigeminal type. Sciatic pain not definitely referred to the sciatic nerve, but diffuse and referred. Gastric and intestinal symp- toms. Group C. Occasional swelling and tenderness in joints or tendons, rapidly clearing up and leaving no objective symptoms. Irregular muscular pains, occa- sionally associated with stiffness. Tingling, or pins- and-needles sensation in the extremities. Local as- phyxias or other vaso-motor phenomena. Intermittent lumbago. Occasional trigeminal neuralgia. These three types gave respectively 25, 16, and 8 cases. Of the total number of cases with a history of rheumatic symptoms, 15 were males and 34 females. Vaccine Treatment : Of the 49 cases, 45 received autogenous vaccines made from the streptobacillus ma- ke. The initial dose was about 10,000,000 which was in most instances followed by an exacerbation of the joint symptoms. The dose was gradually increased to